Dr. Philip is a professor of oncology and pharmacology at the Wayne State University School of Medicine. He is the head of gastrointestinal and neuroendocrine oncology at the Henry Ford Cancer Institute in Detroit. Additionally, he is a co-leader of the Pancreatic Cancer Program. He is the chair of the GI committee of the national collaborative research group SWOG.

Dr. Philip earned his medical degree from the University of Baghdad College of Medicine in Iraq and his PhD in clinical pharmacology and pharmacogenetics from the University of London Guy’s Hospital Medical School in the United Kingdom. He completed a fellowship in medical oncology at the University of Oxford and the M.D. Anderson Cancer Center in Houston. He is board-certified in medical oncology in the United States and a Fellow of the Royal College of Physicians in the United Kingdom.

His primary research interests are focused on developing new therapies for gastrointestinal and neuroendocrine cancers, with a strong emphasis on pancreatic cancer. He has been the principal investigator for several clinical studies. Dr. Philip has published more than 250 manuscripts, review articles, and editorial pieces and is a co-editor of a book on pancreatic cancer and another on gastrointestinal cancers.

Dr. Philip is a member of the scientific advisory board of the Pancreatic Action Network (PanCan), the scientific advisory board of SkyFoundation, and the board of the Michigan Society of Hematology and Oncology.